Auspex Pharmaceuticals
La Jolla
About Auspex Pharmaceuticals
Auspex Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of novel medicines for the treatment of orphan diseases. The company's pipeline includes product candidates to address unmet medical needs in hyperkinetic movement disorders, such as chorea associated with Huntington’s disease, tardive dyskinesia, and Tourette syndrome, as well as other orphan indications.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Delisted
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $123.8M
- Funding stage: M&A
- Last round: Debt Financing (Jan 2014)
- Ticker: nasdaq:ASPX
- Website: auspexpharma.com
- Phone: (760) 599-1800
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Canonical: https://fsome.com/organization/auspex-pharmaceuticals-1868722 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.